← ANALYSTS · TIPRANKS
Kostas Biliouris · Oppenheimer
Hits
41%
129 of 315 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
−0.1%
Over a year after the rating, TipRanks’ measure
Our companies rated now
14
Buy / hold / sell: 13 / 1 / 0
Upside of the analyst’s targets
+261.6%
Average over 14 current targets, to the last price
The market’s answer to the ratings
+4.6%
Day-0 move against SPY in the rating’s direction, average over 6 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 13on TipRanks 07:55 | NRIXIWMNurix Therapeutics · $2.7B | Reiterated | Buy | $28.00 → $32.00+14.3% | +31.0% | −0.1%next day +8.0% | ↗ |
| Oct 7on TipRanks Oct 8 06:00 | PEPGPepGen Inc. · $166M | Reiterated | Buy | $15.00 | +476.9% | +4.1%next day −0.4% · 5 days −2.4% | ↗ |
| Oct 6on TipRanks 08:30 | KRROIWMKorro Bio · $137M | Reiterated | Buy | $22.00 | +159.1% | −2.7%next day +7.7% · 5 days −9.6% | ↗ |
| Sep 25on TipRanks 09:15 | PRMEIWMPrime Medicine, Inc. · $655M | Reiterated | Buy | $11.00 | +217.0% | −6.1%next day −0.1% · 5 days +3.0% | ↗ |
| Sep 9on TipRanks 15:45 | IRDIWMOpus Genetics · $337M | Reiterated | Buy | $10.00 → $20.00+100.0% | +420.8% | +32.5%next day +6.5% · 5 days −4.5% | ↗ |
| Sep 9on TipRanks 07:50 | EVMNIWMEvommune, Inc. · $215M | Reiterated | Buy | $26.00 | +402.9% | −16.7%next day −2.0% · 5 days −12.5% | ↗ |
| Sep 3on TipRanks 07:30 | TRDAIWMEntrada Therapeutics Inc · $177M | Reiterated | Buy | $23.00 | +426.3% | −2.8%next day −0.2% · 5 days −4.0% | ↗ |
| Aug 14on TipRanks 08:15 | OVIDIWMOvid Therapeutics · $428M | Reiterated | Buy | $9.00 | +318.6% | +1.3%next day +2.6% · 5 days +0.3% | ↗ |
| Aug 14on TipRanks 08:15 | PRQRProQR · $228M | Reiterated | Buy | $9.00 | +587.0% | +4.0%next day +1.0% · 5 days +23.2% | ↗ |
| Aug 12on TipRanks 06:30 | LEGNLegend Biotech · $3.5B | Downgrade | Hold | $75.00 → $40.00−46.7% | +116.5% | −5.7%next day −2.5% · 5 days +9.9% | ↗ |
| Aug 6on TipRanks 08:31 | SRPTIWMSarepta Therapeutics · $1.9B | Reiterated | Buy | $37.00 → $35.00−5.4% | +104.7% | +5.5%next day −0.6% · 5 days +8.6% | ↗ |
| Jul 31on TipRanks 08:06 | ALNYQQQAlnylam Pharma · $31.3B | Reiterated | Buy | $500 → $350−30.0% | +51.0% | −0.7%next day +5.8% · 5 days +3.1% | ↗ |
| Jul 10on TipRanks 07:50 | NRIXIWMNurix Therapeutics · $2.7B | Reiterated | Buy | $28.00 | +14.7% | −7.0%next day −0.8% · 5 days +1.8% | ↗ |
| Jun 15on TipRanks 07:50 | DSGNIWMDesign Therapeutics · $656M | Reiterated | Buy | $21.00 | +103.7% | −0.2%next day −3.2% · 5 days +25.9% | ↗ |
| Jun 9on TipRanks 07:00 | DTILIWMPrecision BioSciences · $170M | Initiated | Buy | $20.00 | +246.6% | +1.6%next day −4.4% · 5 days −9.8% | ↗ |
| Mar 13on TipRanks 08:00 | KRROIWMKorro Bio · $137M | Reiterated | Buy | $22.00 | +159.1% | +11.9%next day −2.6% · 5 days −14.2% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗